Managing Methotrexate Toxicity – A Case Report
Journal: International Healthcare Research Journal (Vol.1, No. 1)Publication Date: 2017-04-10
Authors : Kandla Sharma;
Page : 28-32
Keywords : Methotrexate toxicity; Psoriasis; Immunosuppression; Ulceration;
Abstract
Methotrexate, a folic acid analogue is being used globally in the treatment of neoplastic diseases and immunologically mediated disorders. MTX therapy is known to result in mucositis and myelosuppression. Methotrexate associated skin lesions are rare, but they serve as a forewarning signal for later-onset pancytopenia. Therefore, identification of mucosal and skin lesions might help to initiate treatment strategies at an incipient stage. Here we describe a case of methotrexate toxicity who developed mucocutaneous ulcerations and pancytopenia due to methotrexate being given for psoriasis. The provision of rescue therapy led to the amelioration of the symptoms showing the benefit of early recognition and treatment of MTX-induced toxicity.
Other Latest Articles
- ASSESSMENT OF DIFFERENT PARTIAL LEAST SQUARES VARIANTS FOR DETERMINATION OF BINARY-DRUG SYSTEM EXHIBITING INTENSE SPECTRAL OVERLAP
- OSMF and its Prevalence Amongst Rural Shop Owners in Panchkula District, Haryana, India: A Descriptive Study
- Self-Reported Obesity Status of School Teachers Teaching In Various Schools of District Panchkula, Haryana, India
- ISOLATION, CHARACTERIZATION AND ESTIMATION OF MARKER COMPOUND OF VISCUM ALBUM L
Last modified: 2017-07-21 19:27:54